Harrison Farber
- Epoprostenol dosing by concomitant therapies in the PROSPECT registryBy Murali Chakinala, Robert Frantz, Robert Schilz, Wade Benton, Dave Miller, Brian Hartline, Christa-Lynn Vampola, Daniel Rosenberg and Harrison FarberMurali Chakinala1Pulmonary & Critical Care Medicine, Washington University, St. Louis, MO,Robert Frantz2Cardiovascular Diseases, Mayo Clinic, Rochester, MN,Robert Schilz3Department of Medicine-Pulmonary/Critical Care, University Hospitals of Cleveland, Cleveland, OH,Wade Benton4Medical Affairs, Actelion Pharmaceuticals US, Inc., South San Francisco, CA,Dave Miller5Statistical Analysis, ICON Clinical Research, San Francisco, CA,Brian Hartline4Medical Affairs, Actelion Pharmaceuticals US, Inc., South San Francisco, CA,Christa-Lynn Vampola4Medical Affairs, Actelion Pharmaceuticals US, Inc., South San Francisco, CA,Daniel Rosenberg6Epidemiology, Actelion Pharmaceuticals Ltd., Allschwil, SwitzerlandHarrison Farber7Pulmonary Center, Boston University School of Medicine, Boston, MA,
- Calculation of REVEAL scores for patients with PAH receiving riociguat in the PATENT-2 studyBy Raymond Benza, Adaani Frost, Harrison Farber, Hossein-Ardeschir Ghofrani, Miguel Angel Gómez Sánchez, David Langleben, Stephan Rosenkranz, Dennis Busse, Christian Meier, Sylvia Nikkho and Marius HoeperRaymond Benza1Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA United StatesAdaani Frost2Baylor College of Medicine, Division of Cardiovascular Diseases, Houston, TX United StatesHarrison Farber3Pulmonary Center, Boston University School of Medicine, Boston, MA United StatesHossein-Ardeschir Ghofrani4Member of the German Center of Lung Research (DZL), University of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany5Department of Medicine, Imperial College London, London, United KingdomMiguel Angel Gómez Sánchez6Cardiology Service, Hospital Universitario 12 de Octubre, Madrid, SpainDavid Langleben7Center for Pulmonary Vascular Disease and Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, CanadaStephan Rosenkranz8Department of Cardiology, Heart Center, University Hospital of Cologne, Cologne, GermanyDennis Busse9Global Data Sciences and Analytics, Chrestos Concept GmbH & Co. KG, Ratingen, GermanyChristian Meier10Global Clinical Development, Bayer Pharma AG, Berlin, GermanySylvia Nikkho10Global Clinical Development, Bayer Pharma AG, Berlin, GermanyMarius Hoeper11Member of the German Center of Lung Research (DZL), Clinic for Respiratory Medicine, Hannover Medical School, Hannover, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.